BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16321484)

  • 1. HRT use in 2001 and 2004 in The Netherlands--a world of difference.
    de Jong-van den Berg LT; Faber A; van den Berg PB
    Maturitas; 2006 May; 54(2):193-7. PubMed ID: 16321484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
    Leung KY; Ling M; Tang GW
    Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative.
    Main P; Robinson M
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):861-8. PubMed ID: 18504768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant fall in hormone replacement therapy prescription in general practice.
    Lagro-Janssen A; Knufing MW; Schreurs L; van Weel C
    Fam Pract; 2010 Aug; 27(4):424-9. PubMed ID: 20406789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hormone replacement therapy, 1998-2007: sustained impact of the Women's Health Initiative findings.
    Silverman BG; Kokia ES
    Ann Pharmacother; 2009 Feb; 43(2):251-8. PubMed ID: 19193581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of the women's health initiative on HRT.
    Parente L; Uyehara C; Larsen W; Whitcomb B; Farley J
    Arch Gynecol Obstet; 2008 Mar; 277(3):219-24. PubMed ID: 17713777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
    Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK
    J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in Denmark, 1995-2004.
    Løkkegaard E; Lidegaard O; Møller LN; Agger C; Andreasen AH; Jørgensen T
    Acta Obstet Gynecol Scand; 2007; 86(11):1342-51. PubMed ID: 17963062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997.
    North FM; Sharples K
    N Z Med J; 2001 Jun; 114(1133):250-3. PubMed ID: 11453344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation rate of hormone replacement therapy in Hong Kong public health sector.
    Leung KY; Ling M; Tang GW
    Maturitas; 2004 Dec; 49(4):338-44. PubMed ID: 15531131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing hormone therapy--is the decline in prescribing sustained, and are nonhormonal drugs substituted?
    Vegter S; Kölling P; Töben M; Visser ST; de Jong-van den Berg LT
    Menopause; 2009; 16(2):329-35. PubMed ID: 19188855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.